GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » HeartSciences Inc (NAS:HSCS) » Definitions » Days Sales Outstanding

HSCS (HeartSciences) Days Sales Outstanding : 0.00 (As of Jan. 2025)


View and export this data going back to 2022. Start your Free Trial

What is HeartSciences Days Sales Outstanding?

HeartSciences's average Accounts Receivable for the three months ended in Jan. 2025 was $0.00 Mil. HeartSciences's Revenue for the three months ended in Jan. 2025 was $0.00 Mil.

The historical rank and industry rank for HeartSciences's Days Sales Outstanding or its related term are showing as below:

During the past 5 years, HeartSciences's highest Days Sales Outstanding was 146.00. The lowest was 52.14. And the median was 99.07.

HSCS's Days Sales Outstanding is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 65.87
* Ranked among companies with meaningful Days Sales Outstanding only.

HeartSciences's Days Sales Outstanding declined from Jan. 2024 (57.79) to Jan. 2025 (0.00).


HeartSciences Days Sales Outstanding Historical Data

The historical data trend for HeartSciences's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HeartSciences Days Sales Outstanding Chart

HeartSciences Annual Data
Trend Apr20 Apr21 Apr22 Apr23 Apr24
Days Sales Outstanding
- - 52.14 146.00 -

HeartSciences Quarterly Data
Apr20 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.79 - - - -

Competitive Comparison of HeartSciences's Days Sales Outstanding

For the Medical Devices subindustry, HeartSciences's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HeartSciences's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, HeartSciences's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where HeartSciences's Days Sales Outstanding falls into.


;
;

HeartSciences Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

HeartSciences's Days Sales Outstanding for the fiscal year that ended in Apr. 2024 is calculated as

Days Sales Outstanding (A: Apr. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Apr. 2023 ) + Accounts Receivable (A: Apr. 2024 )) / count ) / Revenue (A: Apr. 2024 )*Days in Period
=( (0 + 0) / 1 ) / 0.019*365
=0 / 0.019*365
=0.00

HeartSciences's Days Sales Outstanding for the quarter that ended in Jan. 2025 is calculated as:

Days Sales Outstanding (Q: Jan. 2025 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Oct. 2024 ) + Accounts Receivable (A: Jan. 2025 )) / count ) / Revenue (A: Jan. 2025 )*Days in Period
=( (0 + 0) / 1 ) / 0*365 / 4
=0 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HeartSciences  (NAS:HSCS) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


HeartSciences Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of HeartSciences's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


HeartSciences Business Description

Traded in Other Exchanges
N/A
Address
550 Reserve Street, Suite 360, Southlake, TX, USA, 76092
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
Executives
David R. Wells director 2801 OCEAN PARK BLVD., SUITE 339, SANTA MONICA CA 90405
Bruce Bent director 750 BONHAM PARKWAY, LANTANA TX 76226
Mark T Hilz director, officer: See Remarks 3301 DAKOTA DRIVE, NORTHLAKE TX 76226
Patrick Kanouff director 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Brian Szymczak director 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Danielle Watson officer: See Remarks 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Andrew Simpson director, officer: See Remarks 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092